Valganciclovir

Back to search

Molecule Structure

Scientific Name

Valganciclovir

Description of the Drug

Valganciclovir is an antiviral medication used to treat cytomegalovirus (CMV) retinitis in patients diagnosed with acquired immunodeficiency syndrome (AIDS).

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB01610

Brand Name(s)

Not Available

Company Owner(s)

Mylan Pharmaceuticals Inc, Actavis Laboratories Fl Inc, Hetero Labs Ltd Unit V, Ajanta Pharma Ltd, Cipla Ltd, Hoffmann La Roche Inc, Granules Pharmaceuticals Inc, Dr Reddys Laboratories Ltd, Endo Pharmaceuticals Inc, Aurobindo Pharma Ltd

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Human herpesvirus 1 DNA polymerase SINGLE PROTEIN INHIBITOR CHEMBL1872

Unichem Links

SureChEMBL SCHEMBL28996 SCHEMBL22357189
PharmGKB PA10227
Human Metabolome Database HMDB0015548
WDI DR9802079
DrugBank DB01610
PubChem: Thomson Pharma 15916891 16867892 14852135 16292870 14852136
PubChem 135413535
Nikkaji J1.170.632K
EPA CompTox Dashboard DTXSID8048288
DrugCentral 2801
Brenda 208586 72233 208587
Guide to Pharmacology 4716
rxnorm VALGANCICLOVIR HYDROCHLORIDE VALCYTE VALGANCICLOVIR
ChEBI 63635